• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Centessa Pharmaceuticals plc - American Depositary Shares (NQ:CNTA)

    26.50 -0.47 (-1.74%)
    Streaming Delayed Price Updated: 11:32 AM EST, Feb 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 238,743
    Open 26.92
    Bid (Size) 26.36 (300)
    Ask (Size) 26.50 (200)
    Prev. Close 26.97
    Today's Range 26.00 - 27.12
    52wk Range 9.600 - 30.58
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Biotech Fund Dumps 1.85 Million Centessa Shares as Stock Jumps Over 50% ↗
    Centessa Pharmaceuticals develops clinical-stage therapies for rare and serious diseases, leveraging a portfolio approach in biopharma. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Just Disclosed a New $55 Million Bet on Centessa Amid 53% Stock Rally and CEO Transition ↗
    This UK-based biotech advances clinical-stage therapies for rare diseases, targeting specialty care markets with a diversified pipeline. 
    Via The Motley Fool

    Performance

    YTD
    +11.9%
    +11.9%
    1 Month
    +3.0%
    +3.0%
    3 Month
    -8.6%
    -8.6%
    6 Month
    +59.2%
    +59.2%
    1 Year
    +68.3%
    +68.3%

    More News

    Read More
    News headline image
    Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Centessa Pharmaceuticals plc
    Via GlobeNewswire
    News headline image
    This Fund Locked In Gains With a $14.5 Million Biotech Exit Amid a Staggering Stock Rally ↗
    Via The Motley Fool
    Topics ETFs
    News headline image
    Centessa Pharmaceuticals Announces Poster Presentation of New Preclinical Data Supporting Expansion of Orexin Receptor 2 (OX2R) Agonist Pipeline into Neuropsychiatric Indications at the 64th ACNP Annual Meeting
    From Centessa Pharmaceuticals plc
    Via GlobeNewswire
    News headline image
    This Biotech Fund Exited an $8 Million Edgewise Stake as the Stock Slid Double Digits ↗
    Via The Motley Fool
    News headline image
    Centessa Pharmaceuticals Announces CEO Transition as Company Advances Strategy to Extend Orexin Leadership into Multiple Neuroscience Indications
    From Centessa Pharmaceuticals plc
    Via GlobeNewswire
    News headline image
    What One Fund's Sale of Centessa Stock Signals About the Fast-Rising Biotech Company ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    5AM Venture Just Dumped Its Viking Stake—Smart Call or Missed Opportunity? ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    5AM Venture Bails on MoonLake After a Brutal Year: Here’s What Stands Out ↗
    Via The Motley Fool
    News headline image
    This Biotech Fund Has an $85 Million Bet on Amylyx as Stock Surges 180% and Co-CEOs Tease 'Transformational' Year Ahead ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Biotech Fund Made a New $40 Million Bet on Liquidia Amid Blockbuster Commercial Drug Launch ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Centessa Stock Has Surged 77% Over the Past Year — But a Top Biotech Fund Is Still Buying ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Sold $49 Million of Cidara Stock — Then Merck Announced a $9.2 Billion Takeover ↗
    Via The Motley Fool
    News headline image
    Why Centessa Pharmaceuticals Stock Crushed the Market Today ↗
    Via The Motley Fool
    News headline image
    Neural Gold Rush: Is Brain Data the Most Precious Commodity of the Century?
    Via MarketMinute
    Topics Artificial Intelligence Economy
    News headline image
    Centessa Pharmaceuticals Announces Pricing of $250,000,000 Public Offering of American Depositary Shares
    From Centessa Pharmaceuticals plc
    Via GlobeNewswire
    News headline image
    Centessa Pharmaceuticals Announces Proposed Public Offering of American Depositary Shares
    From Centessa Pharmaceuticals plc
    Via GlobeNewswire
    News headline image
    Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Centessa Pharmaceuticals plc
    Via GlobeNewswire
    News headline image
    These stocks that are showing activity before the opening bell on Wednesday. ↗
    Via Chartmill
    News headline image
    Centessa Pharmaceuticals Reports Financial Results for the Third Quarter of 2025 and Provides Update on Potential Best-in-Class Orexin Receptor 2 (OX2R) Agonist Program
    From Centessa Pharmaceuticals plc
    Via GlobeNewswire
    News headline image
    This Domino's Pizza Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday ↗
    Via Benzinga
    News headline image
    12 Health Care Stocks Moving In Monday's After-Market Session ↗
    Via Benzinga
    News headline image
    CENTESSA PHARMACEUTICALS-ADR (NASDAQ:CNTA) Shows Strong Technical Setup for Potential Breakout ↗
    Via Chartmill
    News headline image
    3 Biotech Stocks Showing Strength With Big Spikes In Momentum Scores ↗
    Via Benzinga

    Frequently Asked Questions

    Is Centessa Pharmaceuticals plc - American Depositary Shares publicly traded?
    Yes, Centessa Pharmaceuticals plc - American Depositary Shares is publicly traded.
    What exchange does Centessa Pharmaceuticals plc - American Depositary Shares trade on?
    Centessa Pharmaceuticals plc - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares?
    The ticker symbol for Centessa Pharmaceuticals plc - American Depositary Shares is CNTA on the Nasdaq Stock Market
    What is the current price of Centessa Pharmaceuticals plc - American Depositary Shares?
    The current price of Centessa Pharmaceuticals plc - American Depositary Shares is 26.50
    When was Centessa Pharmaceuticals plc - American Depositary Shares last traded?
    The last trade of Centessa Pharmaceuticals plc - American Depositary Shares was at 02/26/26 11:32 AM ET
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.